Syntezza Bioscience

Company Overview

Snapshot

Founded in January 2004, Syntezza Bioscience operates with 11–50 employees, providing molecular biology products and services. The company is a key player in the Health Tech & Life Sciences sector, focusing on the development and distribution of specialized biological products.

Business overview

Syntezza Bioscience specializes in providing and distributing molecular biology products and services. Its offerings include custom DNA and RNA oligos, genes, enzymes, peptides, research kits, and reagents, specifically designed for Next-Generation Sequencing (NGS) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) screens. The company also delivers Sanger and NGS sequencing services and undertakes contract research projects within the diagnostics field, serving the pharmaceuticals and life sciences industries.

Company Intelligence Q&A

What is Syntezza Bioscience's primary focus?

Syntezza Bioscience primarily focuses on providing and distributing molecular biology products and services, including custom DNA/RNA oligos, genes, enzymes, peptides, and research kits for applications like NGS and CRISPR screens.

What types of sequencing services does Syntezza Bioscience offer?

Syntezza Bioscience offers both Sanger and Next-Generation Sequencing (NGS) services to support research and diagnostic applications.

In which markets does Syntezza Bioscience operate?

Syntezza Bioscience operates in the Israel and United States markets, providing its molecular biology products and services to customers in these regions.

Does Syntezza Bioscience engage in contract research?

Yes, Syntezza Bioscience leads contract research projects, particularly within the diagnostics field, leveraging its expertise in molecular biology.

What is the primary sector of Syntezza Bioscience?

Syntezza Bioscience operates within the Health Tech & Life Sciences sector, with a specific focus on pharmaceuticals and medical biotechnology.